148 related articles for article (PubMed ID: 24170247)
1. Five-year potency preservation after iodine-125 prostate brachytherapy.
Nishimura S; Yorozu A; Ohashi T; Sakayori M; Yagi Y; Nishiyama T; Saito S; Shiraishi Y; Yoshida K; Toya K; Shigematsu N
Int J Clin Oncol; 2014 Oct; 19(5):940-5. PubMed ID: 24170247
[TBL] [Abstract][Full Text] [Related]
2. Long-term potency preservation following brachytherapy for prostate cancer.
Snyder KM; Stock RG; Buckstein M; Stone NN
BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
[TBL] [Abstract][Full Text] [Related]
3. Erectile function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
[TBL] [Abstract][Full Text] [Related]
4. Erectile function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
[TBL] [Abstract][Full Text] [Related]
5. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
Stock RG; Stone NN; Iannuzzi C
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):267-72. PubMed ID: 8635932
[TBL] [Abstract][Full Text] [Related]
6. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
7. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
Whaley JT; Levy LB; Swanson DA; Pugh TJ; Kudchadker RJ; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e765-71. PubMed ID: 22300559
[TBL] [Abstract][Full Text] [Related]
8. Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.
Ong WL; Hindson BR; Beaufort C; Pharoah P; Millar JL
Radiother Oncol; 2014 Jul; 112(1):72-6. PubMed ID: 25086852
[TBL] [Abstract][Full Text] [Related]
9. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
Solan AN; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
[TBL] [Abstract][Full Text] [Related]
10. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
Stock RG; Kao J; Stone NN
J Urol; 2001 Feb; 165(2):436-9. PubMed ID: 11176391
[TBL] [Abstract][Full Text] [Related]
11. Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
Okihara K; Yorozu A; Saito S; Tanaka N; Koga H; Higashide S; Kikuchi T; Nakano M
Int J Urol; 2017 Jul; 24(7):518-524. PubMed ID: 28455847
[TBL] [Abstract][Full Text] [Related]
12. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
Matsushima M; Kikuchi E; Maeda T; Nakashima J; Sugawara A; Ando T; Mizuno R; Nagata H; Miyajima A; Shigematsu N; Oya M
J Urol; 2013 Mar; 189(3):1014-8. PubMed ID: 23017516
[TBL] [Abstract][Full Text] [Related]
13. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
Pugh TJ; Mahmood U; Swanson DA; Munsell MF; Wang R; Kudchadker RJ; Bruno TL; Frank SJ
Brachytherapy; 2015; 14(2):160-5. PubMed ID: 25255712
[TBL] [Abstract][Full Text] [Related]
14. Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer.
Bazinet A; Zorn KC; Taussky D; Delouya G; Liberman D
Brachytherapy; 2020; 19(2):222-227. PubMed ID: 31837989
[TBL] [Abstract][Full Text] [Related]
15. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
Stone NN; Stock RG
Urology; 2007 Feb; 69(2):338-42. PubMed ID: 17320674
[TBL] [Abstract][Full Text] [Related]
16. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
Keyes M; Pickles T; Crook J; McKenzie M; Cheung A; Spadinger I; LaPointe V; Bachand WF; Morris J
Brachytherapy; 2015; 14(3):334-41. PubMed ID: 25684438
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
Peng LC; Mian OY; Lakshminarayanan P; Huang P; Bae HJ; Robertson S; Habtu T; Narang A; Agarwal S; Greco S; Tran P; McNutt T; DeWeese TL; Song DY
Urology; 2020 Jan; 135():111-116. PubMed ID: 31454660
[TBL] [Abstract][Full Text] [Related]
18. Erectile function after brachytherapy with external beam radiation for prostate cancer.
Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
[TBL] [Abstract][Full Text] [Related]
19. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
Wilder RB; Chou RH; Ryu JK; Stern RL; Wong MS; Ji M; Roach M; White RD
Am J Clin Oncol; 2000 Aug; 23(4):330-3. PubMed ID: 10955856
[TBL] [Abstract][Full Text] [Related]
20. Erectile function status is highly associated with prostate-specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy.
Matsushima M; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Ohashi T; Mikami S; Miyajima A; Shigematsu N; Oya M
Int J Urol; 2016 Mar; 23(3):247-52. PubMed ID: 26663514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
